A distributed regulatory system
Evidence context. Preclinical evidence.
Norepinephrine participates in arousal, autonomic regulation, attention, stress-related responses, and other functions across central and peripheral tissues. Locus coeruleus projections are broad but not necessarily homogeneous.
Distribution matters because the same molecular target may participate in different functions across tissues, projection-defined circuits, levels of endogenous signalling, and physiological states. Target identity alone therefore cannot predict the full consequence of an intervention.
Feedback and physiological state
Evidence context. Aeviant interpretation.
Norepinephrine signalling is regulated through synthesis, release, reuptake, metabolism, receptor signalling, and autoreceptor-mediated feedback. These controls interact rather than operating as isolated switches.
Aeviant interprets this regulatory structure as a reason to test activity-dependent pharmacology: where a mechanism supports it, drug activity may be able to retain some dependence on the body’s own signal instead of being governed by exposure alone. The current evidence does not show that AVX-1 achieves this.
What the biology does not establish
Evidence context. Requires validation.
Circuit and receptor biology can identify a research question. They do not identify a viable molecule, establish a therapeutic window, show neuroprotection, or demonstrate benefit in humans.
AVX-1 remains computational. No physical molecule has been synthesized, no assay has been run, and no intended pharmacological property has been demonstrated experimentally.
Limitations
Much of the mechanistic evidence comes from rodents, brain slices, electrophysiology, optogenetic perturbation, and selected nonhuman-primate recordings. It does not establish a therapeutic mechanism, human translation, or any experimental property of AVX-1.
Relevance to the current program
AVX-1 asks whether the α2A-adrenergic autoreceptor can be modulated in a way that retains dependence on endogenous norepinephrine. That is an Aeviant interpretation of the biology, not an established result.
References and supporting evidence
The following records provide the principal public evidence used in this review. Their classifications and limitations remain part of the interpretation.
The locus coeruleus is broadly connected but internally structured
Viral-genetic tracing in mice found broad locus coeruleus inputs and outputs alongside evidence of subcircuit organization.
Classification. Preclinical evidence.
Relevance to Aeviant. Distributed noradrenergic anatomy is one reason system-level consequences cannot be inferred from target binding alone.
Limitations. Anatomical tracing in mice does not establish human function, uniform broadcasting, or a therapeutic mechanism.
- Viral-genetic tracing of the input–output organization of a central noradrenaline circuit — Schwarz LA et al., Nature, 2015.
Locus coeruleus neurons can exhibit transient stimulus responses
Extracellular recordings in behaving rats identified short-latency transient responses to non-noxious environmental stimuli whose magnitude varied with vigilance.
Classification. Preclinical evidence.
Relevance to Aeviant. These observations support treating noradrenergic signalling as temporally structured rather than as a single static output.
Limitations. The study is correlational, uses rats, and does not establish a universal account of attention, salience, or therapeutic modulation.
- Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli — Aston-Jones G, Bloom FE, Journal of Neuroscience, 1981.
Experimental locus coeruleus activation can produce frequency-dependent effects
Optogenetic work in mice demonstrated a causal relationship between imposed locus coeruleus firing patterns and measures of cortical activity and arousal.
Classification. Preclinical evidence.
Relevance to Aeviant. The study illustrates that timing and pattern can matter to system-level consequences.
Limitations. Optogenetic stimulation can be nonphysiological. Mouse arousal findings do not establish human efficacy or show that any drug preserves endogenous dynamics.
- Tuning arousal with optogenetic modulation of locus coeruleus neurons — Carter ME et al., Nature Neuroscience, 2010.
- Phasic locus coeruleus activity regulates cortical encoding of salience information — Vazey EM, Moorman DE, Aston-Jones G, PNAS, 2018.
Further reading: The α2A-adrenergic autoreceptor, the evidence library, and AVX-1.